Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze ATRA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ATRA investment potential.

What is ATRA stock price today?

Get real-time ATRA stock price, historical data, and price charts on Financhill. Track ATRA performance with our advanced analysis tools.

Is ATRA a good investment?

Evaluate ATRA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ATRA stock?

To buy ATRA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ATRA?

View detailed market capitalization data and company valuation metrics for ATRA on our comprehensive analysis page.

What is the P/E ratio of ATRA?

Use our fundamental analysis tools to view ATRA P/E ratio and compare valuation metrics with industry peers.

What are ATRA earnings?

View ATRA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Atara Biotherapeutics, Inc. Stock Predictions

This AI Layer Just Raised Its Share Price

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

ATRA
Atara Biotherapeutics, Inc.

Last Price:

$14.47

Seasonality Move:

-2.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Still Time to Get In: RAD Intel at $0.85/Share

Atara Biotherapeutics, Inc. Stock Forecast

Over the next 52 weeks, Atara Biotherapeutics, Inc. has on average historically fallen by 6.1% based on the past 11 years of stock performance.
Atara Biotherapeutics, Inc. has fallen lower in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
Is Atara Biotherapeutics, Inc. Stock Undervalued?

The current Atara Biotherapeutics, Inc. [ATRA] share price is $14.20. The Score for ATRA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
ATRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Atara Biotherapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Atara Biotherapeutics, Inc. has on average historically fallen by 6.1% based on the past 11 years of stock performance.

Atara Biotherapeutics, Inc. Stock Rating

Sell

Atara Biotherapeutics, Inc. (ATRA) is a Sell

Is Atara Biotherapeutics, Inc. overpriced?

Atara Biotherapeutics, Inc. has fallen lower in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%

Atara Biotherapeutics, Inc. Stock Price History

Is ATRA stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATRA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

atarabio.com

52-Week Data

52-Week High:

18.71

52-Week Low:

5.01

Prediction Charts

Market Cap:

102.4M

Price in USD:

14.20

Volume:

127.4K

Beta:

1.00

Technical Analysis

SMA50:

14.04

SMA100:

12.94

SMA200:

10.15

52-Wk Change:

14.61%

Stock Predictions

Is Atara Biotherapeutics, Inc. stock public?

Yes, Atara Biotherapeutics, Inc. is a publicly traded company.
What is the Atara Biotherapeutics, Inc. stock quote today?

The Atara Biotherapeutics, Inc. stock price is 14.20 USD today.
How to buy Atara Biotherapeutics, Inc. stock online?

You can buy Atara Biotherapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	13.19	13.76	14.28	13.13
Nov-17	13.65	13.10	13.73	12.78
Nov-18	13.08	13.46	13.75	12.75
Nov-19	13.44	13.74	13.96	13.35
Nov-20	13.94	13.22	15.12	12.93
Nov-21	13.34	13.68	14.19	13.26
Nov-24	13.69	14.03	14.35	13.43
Nov-25	14.20	14.57	14.71	14.01
Nov-26	14.61	14.86	15.28	14.61
Nov-28	15.01	15.10	15.28	14.53
Dec-1	14.77	13.54	14.96	13.54
Dec-2	13.61	12.22	13.68	12.22
Dec-3	12.35	12.55	12.86	12.05
Dec-4	12.55	14.20	14.25	12.55

Atara Biotherapeutics, Inc. Earnings

Atara Biotherapeutics, Inc. Earnings Report: Per Share Atara Biotherapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Atara Biotherapeutics, Inc. Forecast Revenue Growth

Atara Biotherapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Atara Biotherapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.53 per share, and a decrease next year of $0.85 per share.

* Atara Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.